This New Jersey bill mandates that health insurance plans and Medicaid cover medically necessary tests and FDA-approved treatments designed to slow the progression of Alzheimer's disease and related disorders. The law applies to hospital service, medical service, and health service corporation contracts, as well as individual and group health insurance policies issued or renewed in the state. A key provision ensures that these specific Alzheimer's treatments are not subject to step therapy requirements, meaning patients can access them without needing to try other medications first. Additionally, the coverage must be provided at the same level as benefits for other medical conditions.
This bill (A 3434) requires New Jersey dialysis centers to allow patients receiving treatment to be accompanied by a designated support person who can assist with communication, mobility, and care decisions. It directly affects dialysis patients and the centers providing their treatment. Centers must create and display clear written policies for support person access, implement reasonable health/safety rules (without unnecessary restrictions), and train staff on these policies. The New Jersey Department of Health will enforce the law, investigate complaints about denied access, and impose penalties for non-compliance. The law takes effect immediately upon passage.
This bill requires health insurance plans in New Jersey to continue covering adult children with disabilities who are 26 or older, provided they cannot work due to a physical or intellectual disability and are financially dependent on their parent. It amends existing law to extend coverage beyond the standard age limit of 26 for this specific group, ensuring they maintain health insurance through their parent's plan. The bill prohibits denial of coverage based on factors like marriage, having a child, or school status, which commonly affected young adults with disabilities. This change directly impacts young adults with disabilities in New Jersey who would otherwise lose coverage at age 26 but meet the eligibility criteria.
This bill (A 964) creates a 15-member "Nursing Home Emergency Preparedness Study Commission" to analyze how New Jersey nursing homes respond to public health emergencies. The commission will examine nursing home environments, emergency policies, staffing levels, and funding needs during crises, and make recommendations to improve resident safety. It includes state health and human services officials, nursing home industry representatives (appointed by legislative leaders), and family members of residents (appointed by the Governor). The commission must submit a report to the Governor and Legislature within 12 months of its first meeting and then expire. This is a procedural study bill with no immediate policy changes, focusing on future recommendations.
This bill creates a statewide stockpile of essential medicines, vaccines, and medical supplies to be managed by New Jersey's Department of Health and State Office of Emergency Management. The stockpile, funded by state appropriations, will be used during emergencies like natural disasters, disease outbreaks, or public health crises. Key provisions require the state to establish distribution guidelines prioritizing healthcare providers in rural and medically underserved areas, with supplies managed through contracts that may include vendor-managed "virtually sequestered" inventories to prevent expiration. The bill mandates demand planning to determine stockpile contents and quantities based on emergency scenarios.
This bill expands New Jersey's existing requirement for health insurance plans to cover prostate cancer screenings without any out-of-pocket costs. It specifically requires coverage for annual screenings - including digital rectal exams and PSA tests - for men aged 50 and older (asymptomatic) and men aged 40 and older with a family history of prostate cancer or other risk factors. The law applies to most health insurance plans, including high-deductible plans where permitted by federal law, and mandates coverage "to the same extent as for any other medical condition." It does not alter existing coverage for other preventive services but ensures no cost-sharing (like deductibles or copays) applies to these specific screenings.
This bill exempts drug manufacturers and distributors from New Jersey's pharmacy licensing requirements when distributing dialysate drugs and devices used for home dialysis treatment of end-stage renal disease patients. It directly affects dialysis manufacturers, distributors, and patients receiving home dialysis, allowing them to bypass standard pharmacy licensing rules under six specific conditions. Key provisions include requiring FDA approval, direct delivery only upon physician orders, original sealed packaging, and mandatory weekly quality checks by a consultant pharmacist. The law ensures these products are handled safely while streamlining access for patients needing home dialysis.
This New Jersey bill creates a new crime called fertility fraud, which specifically targets licensed health care practitioners who knowingly use a patient's reproductive material without their written consent. Under the law, a practitioner commits this offense if they use their own sperm or eggs or the material of another person to cause a pregnancy without the patient's informed agreement. If convicted of this third-degree crime, the individual faces up to five years in prison, a fine of $15,000, and the mandatory permanent revocation of their medical license. Additionally, the legislation extends the statute of limitations for prosecuting this specific offense to 20 years from the date of the treatment or 10 years from when the victim discovers the fraud, whichever is later.
This bill requires state agencies to assess substance and alcohol use disorder treatment providers for conflicts of interest before approving state funding, licensure, or certification. Providers must submit detailed financial information, board member details, and lists of stakeholders with financial ties. If a conflict is identified that could affect care quality, the provider has 90 days to resolve it or risk losing funding/approval. After resolution, providers must undergo two additional conflict assessments within the next year. The law applies to all licensed or certifying state entities and defines conflicts as situations where outside financial interests might influence treatment decisions.
This bill (A 976) creates a temporary license for nonresident military spouses who move to New Jersey due to a military spouse’s assignment. It allows these spouses to practice certain licensed professions (like nursing or social work) without full New Jersey licensure, provided they hold a current license in another state with equivalent requirements and meet other criteria like recent experience and a clean disciplinary record. Most temporary licenses are valid for one year (extendable once), but licenses for six specific professions (including nursing and social work) are valid for two years. The bill directly affects military spouses relocating with active-duty service members, enabling them to work in their licensed professions while adjusting to their new home state.
